DS-3201b

· Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DS-3201b, covering 2024-01-30 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: DS-3201b in Participants With Lymphomas [Phase 1]